A BMI-23 policy means Eden will treat the woman whose scale says 28 but whose waist, blood pressure, and glucose say 35
It just doesn't always work for everyone, especially when your metabolic state is already compromised
This translated to a 1.6 point drop in BMI, compared to 1.1 for the placebo
They were primarily prescribed for diabetes at first, but many patients have started to turn to them for additional uses that include cardiovascular health and especially weight loss
[20] [21] Women with PCOS frequently experience oligomenorrhoea (infrequent periods) or amenorrhoea (absent periods), making this population particularly relevant when discussing GLP-1 medications and menstrual changes
Go deeper: As WBUR's Priyanka Dayal McCluskey recently reported, the $200 million that BCBS spent on GLP drugs in 2024 was a main driver of why health care premiums for all customers soared this year